Alogliptin in combination with metformin and pioglitazone for the treatment of type 2 diabetes mellitus
Daniel Q Holland, Joshua J NeumillerDepartment of Pharmacotherapy, College of Pharmacy, Washington State University, Spokane, Washington, USAAbstract: Alogliptin is a selective dipeptidyl peptidase-4 inhibitor recently marketed for once-daily administration in the treatment of type 2 diabetes melli...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2014-07-01
|
| Series: | Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy |
| Online Access: | http://www.dovepress.com/alogliptin-in-combination-with-metformin-and-pioglitazone-for-the-trea-a17455 |